02 July 2021 : Review article
Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney Transplantation
Akshta Pai1ADEF*, Joshua T. Swan

DOI: 10.12659/AOT.932249
Ann Transplant 2021; 26:e932249

Figure 2 Time points and rationale for donor-derived cell-free DNA (dd-cfDNA) testing for the proposed AlloSure Routine Testing Schedule (ARTS). AS – AlloSure; CNI – calcineurin inhibitor; MPA – mycophenolic acid; DSA – donor-specific antibodies.